Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

US Patent 9896441 · Granted Feb 20, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use a2021
Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use a2021
Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use a2021
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compo2020
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compo2020
Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use a2020
Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use a2020
Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use a2020
Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-ass2020
Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-ass2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orp2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orp2020